All City of Hope articles
-
NewsChanging the gut microbiome boosts health outcomes for people newly diagnosed with metastatic kidney cancer
Researchers have developed a novel use of biotherapeutic product CBM588 in the treatment of cancer; new research suggests the agent adjusts people’s microbiome, possibly leading to enhanced effectiveness of FDA-approved cancer immunotherapies.
-
NewsScientists report positive immune response against mpox using a vaccine
Scientists at one of the largest cancer research and treatment organizations in the United States show that its COVID-19 vaccine also protects against mpox.